KR101506369B1 - 지방산 모노글리세리드 조성물 - Google Patents

지방산 모노글리세리드 조성물 Download PDF

Info

Publication number
KR101506369B1
KR101506369B1 KR1020117021776A KR20117021776A KR101506369B1 KR 101506369 B1 KR101506369 B1 KR 101506369B1 KR 1020117021776 A KR1020117021776 A KR 1020117021776A KR 20117021776 A KR20117021776 A KR 20117021776A KR 101506369 B1 KR101506369 B1 KR 101506369B1
Authority
KR
South Korea
Prior art keywords
delete delete
pharmaceutical composition
composition according
present
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020117021776A
Other languages
English (en)
Korean (ko)
Other versions
KR20120014553A (ko
Inventor
존 렌
베리 헌트
에드워드 시아
한스 호플랜드
Original Assignee
스티펠 리서치 오스트레일리아 피티와이 리미티드
스티펠 래버러토리즈, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42740006&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR101506369(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 스티펠 리서치 오스트레일리아 피티와이 리미티드, 스티펠 래버러토리즈, 인코포레이티드 filed Critical 스티펠 리서치 오스트레일리아 피티와이 리미티드
Publication of KR20120014553A publication Critical patent/KR20120014553A/ko
Application granted granted Critical
Publication of KR101506369B1 publication Critical patent/KR101506369B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/08—Oxygen or sulfur directly attached to an aromatic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020117021776A 2009-03-20 2010-03-19 지방산 모노글리세리드 조성물 Active KR101506369B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US20263509P 2009-03-20 2009-03-20
US61/202,635 2009-03-20
US21331309P 2009-05-28 2009-05-28
US61/213,313 2009-05-28
PCT/US2010/027905 WO2010108060A1 (en) 2009-03-20 2010-03-19 Fatty acid monoglyceride compositions

Publications (2)

Publication Number Publication Date
KR20120014553A KR20120014553A (ko) 2012-02-17
KR101506369B1 true KR101506369B1 (ko) 2015-03-30

Family

ID=42740006

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020117021776A Active KR101506369B1 (ko) 2009-03-20 2010-03-19 지방산 모노글리세리드 조성물

Country Status (15)

Country Link
US (2) US20110305646A1 (https=)
EP (1) EP2408299B1 (https=)
JP (1) JP5992324B2 (https=)
KR (1) KR101506369B1 (https=)
CN (1) CN102368904B (https=)
AU (1) AU2010226476B2 (https=)
BR (1) BRPI1014529A2 (https=)
CA (1) CA2756047C (https=)
CL (1) CL2011002302A1 (https=)
EA (1) EA022569B1 (https=)
ES (1) ES2437395T3 (https=)
IL (1) IL214887A (https=)
MX (1) MX2011009781A (https=)
PL (1) PL2408299T3 (https=)
WO (1) WO2010108060A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2548998T3 (es) * 2009-05-29 2015-10-22 Palau Pharma, S.A. Composiciones antifúngicas de azol
CA2775393C (en) * 2012-05-02 2014-04-29 Samy Saad Topical non-aqueous pharmaceutical formulations
US8778365B1 (en) 2013-01-31 2014-07-15 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9452173B2 (en) 2013-01-31 2016-09-27 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9446131B2 (en) 2013-01-31 2016-09-20 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9433680B2 (en) 2013-01-31 2016-09-06 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
WO2015146398A1 (ja) * 2014-03-26 2015-10-01 株式会社マンダム デオドラント組成物及びデオドラント剤
CN104672506A (zh) * 2015-02-02 2015-06-03 安徽玉堂雨具有限公司 一种抗菌防霉生物降解塑料及其制备方法
WO2017216722A2 (en) * 2016-06-13 2017-12-21 Vyome Biosciences Pvt. Ltd. Synergistic antifungal compositions and methods thereof
EP3468544A2 (en) * 2016-06-13 2019-04-17 Vyome Therapeutics Limited Synergistic antifungal compositions and methods thereof
AU2020408342B2 (en) * 2019-12-20 2024-02-22 Glaxosmithkline Consumer Healthcare Holdings (Us) Llc Topical pharmaceutical compositions for treating onychomycosis
KR102442047B1 (ko) * 2020-09-10 2022-09-08 서울대학교산학협력단 설페이트와 아민기를 함유하는 지방산 글리세리드 화합물, 이의 생산 방법, 및 용도

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0465423A2 (en) * 1990-06-25 1992-01-08 Research Foundation for Mental Hygiene, Inc. Antimicrobial fatty compositions
DE19540465A1 (de) 1995-10-30 1997-05-07 Beiersdorf Ag Antimycotische Zubereitungen mit einem wirksamen Gehalt an Fettsäurepartialglyceriden
WO2006017594A2 (en) 2004-08-03 2006-02-16 Regents Of The University Of Minnesota Fatty-acid derivatives of glycerol for treating microbial infections

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4067997A (en) * 1975-05-21 1978-01-10 Med-Chem Laboratories Synergistic microbecidal composition and method
FR2613227B1 (fr) * 1987-04-01 1990-12-28 Oreal Compositions pharmaceutiques a base de nitrate de miconazole ou de nitrate d'econazole dans le traitement des infections fongiques des ongles
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
DE4434781A1 (de) * 1994-09-29 1996-04-04 Beiersdorf Ag Verwendung von Fettsäureestern zur Bekämpfung von Superinfektionen
RU2122402C1 (ru) * 1995-07-18 1998-11-27 Научно-производственная фирма "Фаркос" Товарищество с ограниченной ответственностью Средство для лечения и профилактики грибковых заболеваний кожи на основе гризеофульвина
DK0983037T3 (da) * 1998-02-09 2003-09-01 Macrochem Corp Fungicid neglelak
KR20080049148A (ko) * 2000-02-16 2008-06-03 벤트레이 파마슈티칼스, 인코포레이티드 약학적 조성물
JP2004043336A (ja) * 2002-07-10 2004-02-12 Naris Cosmetics Co Ltd 抗菌剤及びそれを配合してなる化粧料
BR0312850B1 (pt) * 2002-07-22 2013-06-04 processo para espessar uma composiÇço condicionadora de cabelo À base de Água e/ou àleo, uso de um copolÍmero, e composiÇço para tratamento pessoal À base de àleo/Água.
US20050165104A1 (en) * 2002-07-24 2005-07-28 Holwerda James G. Biocidal agents and veterinary methods
KR20060015514A (ko) * 2003-04-18 2006-02-17 메르크 파텐트 게엠베하 항미생물 안료
US20050058673A1 (en) * 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
RU2337689C1 (ru) * 2007-04-18 2008-11-10 Общество с ограниченной ответственностью "Фармацевтические технологии" Средство для лечения поверхностных микозов
JP2011518844A (ja) * 2008-04-25 2011-06-30 ナノバイオ コーポレーション 真菌、酵母および糸状菌感染症を治療するためのナノエマルション

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0465423A2 (en) * 1990-06-25 1992-01-08 Research Foundation for Mental Hygiene, Inc. Antimicrobial fatty compositions
DE19540465A1 (de) 1995-10-30 1997-05-07 Beiersdorf Ag Antimycotische Zubereitungen mit einem wirksamen Gehalt an Fettsäurepartialglyceriden
WO2006017594A2 (en) 2004-08-03 2006-02-16 Regents Of The University Of Minnesota Fatty-acid derivatives of glycerol for treating microbial infections

Also Published As

Publication number Publication date
ES2437395T3 (es) 2014-01-10
CA2756047A1 (en) 2010-09-23
IL214887A0 (en) 2011-11-30
CL2011002302A1 (es) 2012-06-22
WO2010108060A1 (en) 2010-09-23
US20110305646A1 (en) 2011-12-15
PL2408299T3 (pl) 2014-03-31
BRPI1014529A2 (pt) 2015-08-25
AU2010226476A1 (en) 2011-09-22
KR20120014553A (ko) 2012-02-17
WO2010108060A8 (en) 2011-12-29
CN102368904A (zh) 2012-03-07
CN102368904B (zh) 2014-03-26
EP2408299A4 (en) 2012-08-15
EA201171150A1 (ru) 2012-03-30
US20180360791A1 (en) 2018-12-20
EP2408299A1 (en) 2012-01-25
JP2012521351A (ja) 2012-09-13
CA2756047C (en) 2016-04-26
EA022569B1 (ru) 2016-01-29
IL214887A (en) 2015-09-24
EP2408299B1 (en) 2013-10-23
MX2011009781A (es) 2011-10-17
AU2010226476B2 (en) 2013-02-07
JP5992324B2 (ja) 2016-09-14

Similar Documents

Publication Publication Date Title
KR101506369B1 (ko) 지방산 모노글리세리드 조성물
US10251885B2 (en) Azole antifungal compositions
EP4255393B1 (en) Topical roflumilast formulation having antifungal properties
US8486978B2 (en) Compositions and methods for treating diseases of the nail
CN1399565A (zh) 一种用于促进伤口愈合和给药的无推进剂喷雾状皮肤贴剂组合物
EP1637132B1 (en) External preparation for athlete´s foot treatment
JP2014508146A (ja) 抗真菌組成物
AU2020408342B2 (en) Topical pharmaceutical compositions for treating onychomycosis
HK40118042A (en) Topical roflumilast formulation having antifungal properties
HK40099803A (en) Topical roflumilast formulation having antifungal properties
HK40099803B (en) Topical roflumilast formulation having antifungal properties
WO2005032557A1 (ja) 抗真菌組成物
WO2007110380A1 (en) Insect bite relief preparation comprising epinastine
MXPA06010192A (es) Composiciones anti-vaginitis que comprenden un triazol

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20110919

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20141030

Comment text: Request for Examination of Application

PA0302 Request for accelerated examination

Patent event date: 20141030

Patent event code: PA03022R01D

Comment text: Request for Accelerated Examination

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20141127

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20150317

PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20150320

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20150320

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20171228

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20171228

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20181227

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20181227

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20191227

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20201224

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20220223

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20230223

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20240226

Start annual number: 10

End annual number: 10